UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2020 » Volume 28, issue 1 (102) » The severity of immunocomplex responses in patients with recurrent depressive disorder

The severity of immunocomplex responses in patients with recurrent depressive disorder

Authors

Type of Article

  • Scientific Article

In the Section

  • DIAGNOSTICS AND TREATMENT OF MENTAL AND DRUG ADDICTION DISORDERS

Key words

Index UDK:
  • 616.895.4-092.612.017.018.2

Abstract

The immunocomplex responses in patients with recurrent depressive disorder (RDD) was studied. It has been established that the concentration of circulating immune complexes incl. most pathogenic average and small molecular fractions and phagocytic activity of monocytes in patients with RDD was changed. Changes in immunocomplex responses were most pronounced when more severely manifested in “Major depressive disorder, recurrent episode, severe without psychotic symptoms”(F33.2).

Pages

  • 51-53

Year / Issue

Download PDF

References

  1. Halyna Handzilevska, Uliana Nikitchuk. The depressive concepts of happiness = Гандзілевська Г., Нікітчук У. Депресивні концепції щастя  // Psychology of  2019. No.  9  (1). С. 64—71. DOI: https://doi.org/10.15330/ps.9.1.64-71.
  2. Golubchikov MV, Orlova NM, Stepanova TV. Mental and Behavioral Disorders as a Cause of the Burden of Disease in Ukraine // Materials of the International Scientific and Practical Conference on World Health Day 2017 "Depression: Let's Talk". Kyiv, April 6-7. К., 2017. С. 3-4.
  3. Zelenskaya K.O., Kraskovskaya T.Y. The main links in the development of autodestructive behavior in modern conditions // Actual issues of neuroscience: collection of abstracts of the All-Ukrainian conference of young scientists and students, Kharkiv, April 26, 2017. С. 27-28.
  4. Koval I. A. Modern approaches to the etiology of depressive disorders, their diagnosis and treatment // Problems of modern psychology. 2015. Pp. 202-211. DOI: https://doi.org/10.32626/2227-6246.2015-28.%p.
  5. Anxiety and depressive states in ATO/JFO participants with arterial hypertension / Kozachok MM, Seliuk MM, Omelyashko MI [et al] // Family Medicine. 2019. № 3. С. 43-46. URL: http://nbuv.gov.ua/UJRN/simmed_2019_3_10.
  6. Kornienko V. V., Solona V. P. Psychological features of suicidal behavior of persons with depression // Psychological and Pedagogical Scientific Collection. 2018. № 15. С. 156-161.
  7. Lapach S. N., Chubenko A. V. V., Babich P. N. Statistical methods in medical and biological research using Excel. Kiev : Morion, 2001. 408 с.
  8. Analysis of the subjective perception of their condition by patients with depressive disorders." / Maruta N.O., Fedchenko V.Y., Kalenska G.Y. [et al. 2016. No. 11 (1). С. 58-67.
  9. Fedchenko V. Y. Features of time perception in the dynamics of depressive disorders // Medical Psychology. 2018. VOL. 13, NO. PP. 80-85. http://nbuv.gov.ua/UJRN/Mpsl_2018_13_4_19.
  10. Frolov VM, Rychnev V. E., Peresadin NA Study of circulating immune complexes: diagnostic and prognostic value // Laboratory Business. E., Peresadin N. A. Study of circulating immune complexes: diagnostic and prognostic value // Laboratory business. 1986. № 3. С. 159-161.
  11. Frolov VM, Peresadin NA, Gavrilova LA Determination of phagocytic activity of peripheral blood monocytes in patients // Ibid. 1990. № 3. С. 27-29.
  12. Haustova O. Resistant depression: definition criteria, risk factors and therapeutic strategies // Psychosomatic Medicine and General Practice. 2017. № 2 (3). DOI: https://doi.org/e020338-e020338.
  13. Influence of the migration factor on the course of depressive disorders in migrants and re-emigrants / S.I. Shkrobot, O.P. Venger, O.E. Smashna [et al. 2017. Vol. 25, No. 1, pp. 162-163.
  14. Baldessarini R. J. Epidemiology of suicide: recent developments // Epidemiol Psychiatr Sci. 2019 Nov 7; 29: e71. DOI: https://doi.org/10.1017/S2045796019000672.
  15. Chen J., Hu S. Individualized treatment strategy for depressive disorder / J. Chen // Adv Exp Med Biol. 2019. No. 1180. Р. 219—232. DOI: https://doi.org/10.1007/978-981-32-9271-0_12.
  16. Wesselhoeft T. Childhood depressive disorders  // Dan Med J. 2016 Oct; 63 (10). PII: B5290.
  17. The role of chemokines in the pathophysiology of major depressive disorder / V.   Milenkovic, E.  H.  Stanton, C.  Nothdurfter [et  al.]  // Int  J  Mol  Sci. 2019. Vol. 9, No.  20  (9). Р. 101—109. DOI: https://doi.org/10.3390/ijms20092283.
  18. Wang Z., Ma X., Xiao C. Standardized treatment strategy for depressive disorder // Adv Exp  Med  2019. No.  1180. Р. 193—199. DOI: https://doi.org/10.1007/978-981-32-9271-0_10.
  19. The Effects of psychological stress on depression / L. Yang, Y. Zhao, Y. Wang [et al.] // Curr Neuropharmacol. 2015. No. 13 (4). Р. 494—504. DOI: https://doi.org/10.2174/1570159X1304150831150507.
  20. Zhao G., Liu Neuroimmune Advance in Depressive Disorder  // Adv  Exp  Med  Biol. 2019. No.  1180. Р.  85—98. DOI: https://doi.org/10.1007/978-981-32-9271-0_4.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»